Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

SRSF2 Mutations Impair Nuclear Aggregation and Represent a Novel Mechanism Of Spliceosomal Dysregulation In CMML

Eric Padron, MD, Sateesh Kunigal, PhD, Xiaoyi Ren, Jeffrey S. Painter, B.S., Rainer Metcalf, Joseph Johnson, Ling Zhang, MD, Jeffrey E Lancet, MD, Rami S Komrokji, MD, Kenyon Daniels, PhD, Alan List, MD, Pearlie K Epling-Burnette, PhD

Blood (2013) 122 (21): 260.

https://doi.org/10.1182/blood.V122.21.260.260

Published: 2013

Journal Articles

GM-CSF Signaling Abnormalities in Chronic Myelomonocytic Leukemia

Eric Padron, MD, Jeffrey S. Painter, B.S., Adam W Mailloux, PhD, Jessica M. McDaniel, BS, Christopher Bebbington, DPhil., Mark Baer, PhD, Rami S. Komrokji, MD, Alan F. List, MD, Pearlie K Epling-Burnette, Pharm D, PhD

Blood (2011) 118 (21): 1713.

https://doi.org/10.1182/blood.V118.21.1713.1713

Published: 2011

Journal Articles

Human Telomerase Reverse Transcriptase (hTERT) Deficiency in Myelodysplastic Syndrome (MDS) Demonstrates Mechanistic Linkage to Aplastic Anemia Pathophysiology

Lili Yang, PhD, Adam W Mailloux, PhD, Dana E Rollison, PhD, Jong Park, PhD, Jeffrey S. Painter, B.S., Rami S. Komrokji, MD, Jaroslaw P Maciejewski, MD, PhD, Ronald Paquette, MD, PhD, Thomas P. Loughran, Jr., MD, Sheng Wei, MD, Alan F. List, MD, Pearlie K Epling-Burnette, Pharm D, PhD

Blood (2011) 118 (21): 791.

https://doi.org/10.1182/blood.V118.21.791.791

Published: 2011

Journal Articles

Positive Impact of T-Cell Clonal Expansion On Overall Survival in Patients with High-Risk Myelodysplastic Syndromes.

Amber Schmidt, Rami S. Komrokji, MD, Jeffrey S. Painter, B.S., Dana E Rollison, PhD, Ling Zhang, MD, Lynn C. Moscinski, MD, Alan F List, MD, P.K. Epling-Burnette, PhD

Blood (2009) 114 (22): 1572.

https://doi.org/10.1182/blood.V114.22.1572.1572

Published: 2009

Journal Articles

Functional T Cell Array Reveals Pre-Treatment Expanded Terminal Effector Memory Response Is Associated with Lenalidomide Failure in Non-Del(5q) Myelodysplastic Syndrome.

P.K. Epling-Burnette, PhD, JianXiang Zou, MD, Jeffrey S. Painter, B.S., Dung-Tsa Chen, Jimmy Fulp, Rami S. Komrokji, MD, Sheng Wei, MD, Alan F List, MD

Blood (2009) 114 (22): 1759.

https://doi.org/10.1182/blood.V114.22.1759.1759

Published: 2009

Journal Articles

Pathogenetic Role of Impaired Telomere Repair in Myelodysplastic Syndrome.

P.K. Epling-Burnette, PhD, Alan F List, MD, Justine Clark, MS, Ji-Hyun Lee, Kristen A. Jonathan, William Fulp, Xiaohong Li, Weipeng Zheng, Jeffrey S. Painter, B.S., JianXiang Zou, MD, Rami S. Komrokji, MD, Sheng Wei, MD, Jong Park, Amber Schmidt, Undergraduate, student, Chiharu Sugimori, MD, Ashley Cole, Dana E Rollison, PhD

Blood (2009) 114 (22): 2777.

https://doi.org/10.1182/blood.V114.22.2777.2777

Published: 2009

Journal Articles

A Comprehensive Lymphocyte Analysis of Dasatinib Treated Chronic Myelogenous Leukemia Patients Reveals T-Cell Oligoclonality.

John J. Powers, B.S., Jeffrey S. Painter, B.S., Jason A Dubovsky, B.S., P.K. Epling-Burnette, PharmD, PhD, Javier Pinilla, MD, PhD

Blood (2008) 112 (11): 1114.

https://doi.org/10.1182/blood.V112.11.1114.1114

Published: 2008

Journal Articles

Reduced Inhibitory KIR Receptors in Patients with NK-Lymphoproliferative Disease of Large Granular Lymphocytes (NK-LDGL) Leads to Dysregulated Killing.

P.K. Epling-Burnette, Ph.D., Fanqi Bai, M.D., Jeffrey S. Painter, B.S., Sheng Wei, M.D., Julie Y. Djeu, Ph.D., Thomas P. Loughran, M.D.

Blood (2004) 104 (11): 2661.

https://doi.org/10.1182/blood.V104.11.2661.2661

Published: 2004

Journal Articles

Apoptosis by Low-Dose Methotrexate Occurs in Fully Activated Proliferating CD4 + and CD8 + Lymphocytes and in Leukemic LGL after Mitogenic Stimulation using a FADD-Dependent Pathway.

P.K. Epling-Burnette, Ph.D., Jeffrey S. Painter, B.S., Fanqi Bai, M.D., Subra Mohaptra, Ph.D., Thomas P. Loughran, M.D.

Blood (2004) 104 (11): 2666.

https://doi.org/10.1182/blood.V104.11.2666.2666

Published: 2004

NARROW

SRSF2 Mutations Impair Nuclear Aggregation and Represent a Novel Mechanism Of Spliceosomal Dysregulation In CMML

GM-CSF Signaling Abnormalities in Chronic Myelomonocytic Leukemia

Human Telomerase Reverse Transcriptase (hTERT) Deficiency in Myelodysplastic Syndrome (MDS) Demonstrates Mechanistic Linkage to Aplastic Anemia Pathophysiology

Positive Impact of T-Cell Clonal Expansion On Overall Survival in Patients with High-Risk Myelodysplastic Syndromes.

Functional T Cell Array Reveals Pre-Treatment Expanded Terminal Effector Memory Response Is Associated with Lenalidomide Failure in Non-Del(5q) Myelodysplastic Syndrome.

Pathogenetic Role of Impaired Telomere Repair in Myelodysplastic Syndrome.

A Comprehensive Lymphocyte Analysis of Dasatinib Treated Chronic Myelogenous Leukemia Patients Reveals T-Cell Oligoclonality.

Reduced Inhibitory KIR Receptors in Patients with NK-Lymphoproliferative Disease of Large Granular Lymphocytes (NK-LDGL) Leads to Dysregulated Killing.

Apoptosis by Low-Dose Methotrexate Occurs in Fully Activated Proliferating CD4 + and CD8 + Lymphocytes and in Leukemic LGL after Mitogenic Stimulation using a FADD-Dependent Pathway.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only